As the global economy mends, the 2021 growth of Varicella Live Vaccine will have significant change from previous year. According to our (LP Information) latest study, the global Varicella Live Vaccine market size is USD million in 2022 from USD 2318.6 million in 2021, with a change of % between 2021 and 2022. The global Varicella Live Vaccine market size will reach USD 2914.2 million in 2028, growing at a CAGR of 3.3% over the analysis period.
The United States Varicella Live Vaccine market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Varicella Live Vaccine market, reaching US$ million by the year 2028. As for the Europe Varicella Live Vaccine landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Varicella Live Vaccine players cover Astellas Pharma Inc., CSL Limited, Emergent BioSolutions, Inc., and GlaxoSmithKline plc, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Varicella Live Vaccine market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
Monovalent Vaccines
Multivalent Vaccines
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Chicken Pox Immunization
Herpes Zoster Immunization
Measles Immunization
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
Astellas Pharma Inc.
CSL Limited
Emergent BioSolutions, Inc.
GlaxoSmithKline plc
Johnson & Johnson
MedImmune, LLC
Merck & Co., Inc.
Pfizer, Inc.
Sanofi Pasteur
Serum Institute of India Pvt. Ltd.
Bavarian Nordic
Mitsubishi Tanabe Pharma Corporation
Daiichi Sankyo
Biological E
Panacea Biotec